logo
Select company
Select metric
$ -22.09EBITDA per Share
VS
Market
1
Sector
2
Industry
2
History
100
$ 2.3Close
$ 2.18 - $ 8.93 52-Week Range
Ticker Information

Ticker

VERO

Company Name

VENUS CONCEPT INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VENUS CONCEPT INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VERO - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -32.23M$ -22.0911.46M
3/31/2025$ -39.22M$ -55.321709K
12/31/2024$ -36.83M$ -55.811660K
9/30/2024$ -38.16M$ -57.871659.54K
6/30/2024$ -38.26M$ -64.251595.46K
3/31/2024$ -26.52M$ -50.051529.91K
12/31/2023$ -26.31M$ -53.191494.73K
9/30/2023$ -26.5M$ -52.741502.45K
6/30/2023$ -32.19M$ -64.731497.36K
3/31/2023$ -35.98M$ -75.851474.36K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VENUS CONCEPT INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -281.64.
  • Over the past 5 years, VENUS CONCEPT INC's average EBITDAPS has been $ -83.7.
  • The median EBITDAPS for VENUS CONCEPT INC during this period was $ -59.15
  • VENUS CONCEPT INC reached its highest EBITDAPS over the past 5 years at $ -22.09.
  • The lowest EBITDAPS recorded by VENUS CONCEPT INC in the same timeframe $ -319.59

VENUS CONCEPT INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
NUWE : NUWELLIS INC $ -18.64NAOV : NANOVIBRONIX INC $ -8.93MOVE : MOVANO INC $ -25.56BBLG : BONE BIOLOGICS CORP $ -7.57VTAK : CATHETER PRECISION INC $ -21.53SSKN : STRATA SKIN SCIENCES INC $ -1.06TIVC : TIVIC HEALTH SYSTEMS INC $ -6.88AMIX : AUTONOMIX MEDICAL INC $ -3.79AEMD : AETHLON MEDICAL INC $ -5.76JAGX : JAGUAR HEALTH INC $ -38.13

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for VENUS CONCEPT INC is calculated as follows: EBITDA [ $ -69.07M ] / (Shares WA [ 245.25K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -281.64 ]

VERO - EBITDA per Share, Last 5 years

$ -319.59

Minimum

Dec 31, 2020

$ -22.09

Maximum

Jun 30, 2025

$ -83.7

Average

$ -59.15

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26